Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection

The circulating levels of IL-10 and fibronectin may reflect progression of HCC. Thus, monitoring these biomarkers may benefit HCC progression evaluation.